Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,630.00
Bid: 2,610.00
Ask: 2,625.00
Change: 60.00 (2.33%)
Spread: 15.00 (0.575%)
Open: 2,525.00
High: 2,630.00
Low: 2,525.00
Prev. Close: 2,570.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
22nd Jun 202011:27 amRNSDirector Declaration
18th Jun 20202:02 pmRNSHolding(s) in Company
10th Jun 202012:02 pmRNSPrice Monitoring Extension
1st Jun 202011:48 amRNSTotal Voting Rights
28th May 20202:52 pmRNSDirector/PDMR Shareholding
13th May 20209:00 amRNSAdditional Listing
7th May 20201:30 pmRNSResult of AGM
7th May 20207:00 amRNSAGM Trading Update
1st May 202010:54 amRNSTotal Voting Rights
1st May 202010:37 amRNSChange in Director's details
27th Apr 202010:40 amRNSDisclosure of rights attached to equity shares
20th Apr 20201:10 pmRNSBlock listing Interim Review
2nd Apr 20202:57 pmRNSAnnual Financial Report
1st Apr 202012:08 pmRNSTotal Voting Rights
25th Mar 20207:00 amRNSCOVID-19 Update
11th Mar 20203:45 pmRNSHolding(s) in Company
11th Mar 20208:30 amRNSAdditional Listing
9th Mar 20202:33 pmRNSHolding(s) in Company
9th Mar 20202:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20202:14 pmRNSHolding(s) in Company
2nd Mar 20204:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSTotal Voting Rights
27th Feb 20202:02 pmRNSHolding(s) in Company
27th Feb 20201:48 pmRNSHolding(s) in Company
27th Feb 20201:39 pmRNSHolding(s) in Company
27th Feb 202010:35 amRNSDirector/PDMR Shareholding
24th Feb 20205:45 pmRNSSophos Group
20th Feb 20207:00 amRNSFinal Results
3rd Feb 20204:20 pmRNSTotal Voting Rights
31st Jan 20203:44 pmRNSHolding(s) in Company
29th Jan 20204:18 pmRNSHolding(s) in Company
24th Jan 20203:25 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSDirectorate Change
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.